Jensterle M - Search Results

1

The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.

Jensterle M, Janez A, Fliers E, DeVries JH, Vrtacnik-Bokal E, Siegelaar SE. Jensterle M, et al. Hum Reprod Update. 2019 Jul 1;25(4):504-517. doi: 10.1093/humupd/dmz019. Hum Reprod Update. 2019. PMID: 31260047 Review.

2

Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series.

Jensterle M, Janez A, Vrtovec B, Meden-Vrtovec H, Pfeifer M, Prezelj J, Kocjan T. Jensterle M, et al. Croat Med J. 2007 Dec;48(6):864-70. doi: 10.3325/cmj.2007.6.864. Croat Med J. 2007. PMID: 18074422 Free PMC article.

3

Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.

Jensterle M, Janez A, Mlinar B, Marc J, Prezelj J, Pfeifer M. Jensterle M, et al. Eur J Endocrinol. 2008 Jun;158(6):793-801. doi: 10.1530/EJE-07-0857. Epub 2008 Mar 5. Eur J Endocrinol. 2008. PMID: 18322300 Clinical Trial.

4

Assessment of insulin resistance in young women with polycystic ovary syndrome.

Jensterle M, Weber M, Pfeifer M, Prezelj J, Pfutzner A, Janez A. Jensterle M, et al. Int J Gynaecol Obstet. 2008 Aug;102(2):137-40. doi: 10.1016/j.ijgo.2008.03.017. Epub 2008 May 27. Int J Gynaecol Obstet. 2008. PMID: 18504045

5

Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome.

Jensterle M, Sebestjen M, Janez A, Prezelj J, Kocjan T, Keber I, Pfeifer M. Jensterle M, et al. Eur J Endocrinol. 2008 Oct;159(4):399-406. doi: 10.1530/EJE-08-0507. Epub 2008 Jul 24. Eur J Endocrinol. 2008. PMID: 18653546 Clinical Trial.

6

Decreased lipin 1 beta expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome.

Mlinar B, Pfeifer M, Vrtacnik-Bokal E, Jensterle M, Marc J. Mlinar B, et al. Among authors: jensterle m. Eur J Endocrinol. 2008 Dec;159(6):833-9. doi: 10.1530/EJE-08-0387. Epub 2008 Oct 1. Eur J Endocrinol. 2008. PMID: 18829900

7

Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.

Steiner CA, Janez A, Jensterle M, Reisinger K, Forst T, Pfützner A. Steiner CA, et al. Among authors: jensterle m. J Diabetes Sci Technol. 2007 Mar;1(2):211-7. doi: 10.1177/193229680700100212. J Diabetes Sci Technol. 2007. PMID: 19888409 Free PMC article.

8

Phosphodiesterase 4 inhibition as a potential new therapeutic target in obese women with polycystic ovary syndrome.

Jensterle M, Kocjan T, Janez A. Jensterle M, et al. J Clin Endocrinol Metab. 2014 Aug;99(8):E1476-81. doi: 10.1210/jc.2014-1430. Epub 2014 May 13. J Clin Endocrinol Metab. 2014. PMID: 24823465 Clinical Trial.

9

Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.

Jensterle M, Kocjan T, Kravos NA, Pfeifer M, Janez A. Jensterle M, et al. Endocr Res. 2015;40(3):133-8. doi: 10.3109/07435800.2014.966385. Epub 2014 Oct 20. Endocr Res. 2015. PMID: 25330463 Clinical Trial.

10

A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.

Jensterle M, Kravos NA, Pfeifer M, Kocjan T, Janez A. Jensterle M, et al. Hormones (Athens). 2015 Jan-Mar;14(1):81-90. doi: 10.1007/BF03401383. Hormones (Athens). 2015. PMID: 25885106 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters